Valeria Gutowski - 18 Jan 2024 Form 3 Insider Report for Enfusion, Inc.

Role
Chief Accounting Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Jan 2024
Net transactions value
$0
Form type
3
Filing time
19 Jan 2024, 17:25:59 UTC
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENFN Class A Common Stock 17,597 18 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13,159 restricted stock units awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest as follows: 2,238 on each of January 5, 2025 and 2026; 77 on each of February 28, 2024, 2025 and 2026; 4,226, on each of June 15, 2024 and 2025.

Remarks:

Exhibit 24 - Power of Attorney